.

Avrobio Inc reported 142.08M in Current Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Akebia Therapeutics AKBA:US $ 304.16M 1.48M
Alnylam Pharmaceuticals ALNY:US $ 2471.64M 118.04M
Applied Genetic Technologies AGTC:US $ 49.56M 20.97M
Bluebird Bio BLUE:US $ 167.46M 87.46M
Epizyme EPZM:US $ 186.84M 41.87M
Gilead Sciences GILD:US $ 13705M 1076M
Intercept Pharmaceuticals ICPT:US $ 487.02M 9.66M
IONIS PHARMACEUT IONS:US $ 2191.15M 61.98M
Karyopharm Therapeutics KPTI:US $ 242.45M 34.09M
Macrogenics MGNX:US $ 167.63M 50.57M
Sangamo Biosciences SGMO:US $ 343.12M 3.06M
Sarepta Therapeutics SRPT:US $ 2469.3M 61.65M
Takeda 4502:JP Y 2549515M 44127M